The bottleneck in the development of new molecular therapies is the limited number of new active substances that can be found using current techniques. A method developed in the 2000s at Harvard and ...

The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to ...

Cancers that have high levels of the commonly found cancer biomarker epidermal growth factor receptor (EGFR) has had limited ...

Wearable, long-term continuous heart monitors helped identify 52% more cases of atrial fibrillation compared to usual care, but that did not lead to a reduction in hospitalizations due to stroke, ...

Finerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and cardiovascular death in patients with HF and mildly reduced or ...

New research shows that a treatment plan based on novel combination of low doses of three anti-hypertensive drugs in a single pill - known as GMRx2 - was superior to a high-quality standard care ...

Brigham researchers assessed data from more than 27,000 participants in the Women’s Health Study who were followed for 30 years. An initial, one-time measure of three biological markers—hsCRP, ...

About The Study: Among Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieved better blood pressure lowering and control with good tolerability compared with the ...

A research team led by Professor Kotohiro Nomura from Tokyo Metropolitan University has developed a method for the ...

For atrial fibrillation after cardiac surgery prophylaxis, supplementation only when serum potassium concentration fell below 3.6 mEq/L was noninferior to the current widespread practice of ...

Research supported by the National Institutes of Health has found that measuring two types of fat in the bloodstream along with C-reactive protein (CRP), a marker of inflammation, can predict a ...

Patients with heart failure, a condition affecting more than 60 million worldwide, are four times more likely to receive the optimal combination of medications after 12 weeks of digital consultations.